CVS Group – Profits Are Best In Show Once More

0
CVS Group – Profits Are Best In Show Once More
jaminriverside / Pixabay

Like-for-like sales rose 17.4% for the full year, helped by a strong end to the last quarter as the group lapped last year when clinics were affected by restrictions. CVS Group Plc (LON:CVSG) now expects underlying cash profits (EBITDA) to be slightly ahead of the upgraded targets announced at the end of April. EBITDA margins are expected to be higher than the 18.4% seen at the half year, and the 16.6% reported last year.

Get The Full Henry Singleton Series in PDF

Get the entire 4-part series on Henry Singleton in PDF. Save it to your desktop, read it on your tablet, or email to your colleagues

Q2 2021 hedge fund letters, conferences and more

The group expects full year net debt to be “significantly” below underlying cash profits. CVS said it’s “well placed to pursue further targeted acquisitions”.

How Warren Buffett Turned Three Deep Value Stocks Into A $700 Billion Conglomerate

Warren BuffettIt took decades for Warren Buffett to build Berkshire Hathaway into the conglomerate it is today. Along the way, the Oracle of Omaha and his business partners have acquired a range of different companies and extracted cash from failing businesses to reinvest back into growth stocks. Q2 2021 hedge fund letters, conferences and more The Read More


More detailed full year results are expected on 23 September 2021.

The shares rose 2.2% following the announcement.

CVS Group's Clinics Thrive During The Pandemic

Sophie Lund-Yates, senior equity analyst at Hargreaves Lansdown commented:

“Pandemic or no pandemic, the UK still needs to care for its pets. While there was some disruption to service because of restrictions, on the whole CVS Group’s vet clinics fared much better than other businesses. As restrictions have allowed clinics to offer a wider range of treatments once more, business has boomed, allowing full year profit expectations to be upgraded yet again. A best-in-show performance is especially welcome given the group’s arguably frothy valuation. CVS Group has reached the point where even a good performance could see the share price wobble, so its results need to stand out from the crowd.

CVS Group is also likely being buoyed by the phenomenal rise in pet ownership brought about during lockdowns, which should act as a long-term boon. CVS Group’s revenues are particularly attractive, because once a pet owner registers an animal with a clinic, they’re very likely to be a repeat customer over its lifetime. Recurring revenues are somewhat of a luxury in the world of business, adding a layer of certainty others could only hope for.”


About Hargreaves Lansdown

Over 1.6 million clients trust us with £132.9 billion (as at 30 April 2021), making us the UK’s largest digital wealth management service. More than 98% of client activity is done through our digital channels and over 600,000 access our mobile app each month.

Previous article Wm Morrison – Bidding War Cools Down
Next article Powell Gave Congress Dovish Signs. Will It Help Gold?
Jacob Wolinsky is the founder of ValueWalk.com, a popular value investing and hedge fund focused investment website. Jacob worked as an equity analyst first at a micro-cap focused private equity firm, followed by a stint at a smid cap focused research shop. Jacob lives with his wife and four kids in Passaic NJ. - Email: jacob(at)valuewalk.com - Twitter username: JacobWolinsky - Full Disclosure: I do not purchase any equities anymore to avoid even the appearance of a conflict of interest and because at times I may receive grey areas of insider information. I have a few existing holdings from years ago, but I have sold off most of the equities and now only purchase mutual funds and some ETFs. I also own a few grams of Gold and Silver

No posts to display